Specifically, McKean-Cowdin et al.72 proposed that mutations in DDR genes were associated with an increased risk of glioblastoma multiforme (GBM), and a variant of PRKDC increased the risk of glioma by 44%. This evidence concerns the gene PRKDC and central nervous system cancer.